CHARLESTON, S.C., Sept. 10, 2010 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation (“Revolutions Medical” or the “Company”) (OTCBB:RMCP) to receive contract with the United States Department of Defense HIV/AIDS Prevention Program (DHAPP) for multiple countries for its proprietary 3cc RevVac Safety Syringe.
